News
Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.
2d
TipRanks on MSNBristol-Myers Squibb’s Promising Phase 3 Lung Cancer Study: What Investors Need to Know
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
Stage-four cancer patients are living longer, challenging the idea of what it means to have and survive cancer. “The science ...
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that pivotal ...
Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that new data will be presented at the IASLC 2025 ...
Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses ...
"If approved, the GM Purple Tomato will be sold fresh, as a whole tomato, or used as an ingredient in processed food products such as sun-dried tomatoes or pastes," it said.
To detect ROS1 rearrangement in NSCLC, three different assays including fluorescent in stiu hybridization (FISH), Amoy Dx reverse transcription polymerase chain reaction (RT-PCR) and Oncomine Dx ...
Aligned with FDA on NDA submission strategy for TKI pre-treated patients with advanced ROS1-positive NSCLC and participation in Real-Time Oncology Review; the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results